CME Outfitters Announces New neuroscienceCME Webcast: "Establishing Best Practices for Lipid Measurement in Patients with Bipolar Disorder"

Share Article

Offered as a live webcast/audioconference premiering Tuesday, March 8, 2011, from 12:00 p.m.-1:00 p.m. ET, the continuing education activity seeks to increase clinician performance against the STABLE measure related to assessment for hyperlipidemia in patients with bipolar disorder who are being treated with an atypical antipsychotic agent.

CME Outfitters, LLC, (CMEO) an award-winning accredited provider of multidisciplinary continuing education (CE), in co-sponsorship with USF Health, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME Webcast titled "Establishing Best Practices for Lipid Measurement in Patients with Bipolar Disorder".

Premiering Tuesday, March 8, 2011, from 12:00 p.m.-1:00 p.m. ET, this neuroscienceCME Webcast features Paul E. Keck, Jr., MD, President-CEO of the Lindner Center of HOPE and Professor of Psychiatry & Behavior Neuroscience at the University of Cincinnati College of Medicine. J. Sloan Manning, MD, Adjunct Associate Professor in the Department of Family Medicine at the University of North Carolina at Chapel Hill, will join Dr. Keck for a presentation and discussion followed by a live question and answer session.

Live participation options include a webcast and simultaneous telephone audioconference. The activity will also be available as an archived webcast, podcast, and teleconference shortly after the live webcast. Clinicians can earn up to 1.0 CE credits by participating in the activity, then completing a post-test and evaluation online at neuroscienceCME.com.

There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR545 and click the Register for Live Webcast icon.
Phone: Call 877.CME.PROS (877.263.7767).
Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR545, click the Activity Details icon, print and complete the activity details form, and fax to 614.929.3600.

Statement of Need:
Patients with bipolar disorder (BPD) have an increased prevalence of metabolic syndrome and its numerous component risk factors, including dyslipidemia. Recognition of this fact led to the release of joint recommendations from the American Psychiatric Association (APA) and the America Diabetes Association (ADA) regarding metabolic assessment and management in patients with severe mental illness. It also served as an impetus to develop evidence-based measures such as the STandards for BipoLar Excellence (STABLE) project. The measure regarding dyslipidemia encourages a high benchmark for clinician performance regarding "the percentage of patients diagnosed with bipolar disorder and treated with an atypical antipsychotic agent who receive at least one assessment for hyperlipidemia within the initial 16 weeks of treatment."

A previous, neuroscienceCME Live and On Demand activity in December 2010 discussed the rationale for lipid measurement in this patient population, established underperformance of such measurement as an important practice gap, and outlined strategies for increasing lipid measurement.

This neuroscienceCME Webcast (reinforcing activity) will further assist clinicians in identifying how to customize and implement a process for increasing lipid measurement that works within their own clinical setting.

Learning Objectives:
At the end of this CE activity, participants should be able to:

  • Express attitudinal competence regarding the call to action to improve rates of appropriate lipid measurement in patients with BPD.
  • Skillfully and confidently use patient-centered counseling messages to explain the rationale for lipid measurement to patients with BPD who take atypical antipsychotic agents.
  • Increase the rate at which they perform baseline lipid assessment, in accordance with specified APA/ADA joint recommendations and the STABLE measure for dyslipidemia assessment.

Target Audience:
Physicians, physician assistants, nurses, nurse practitioners, psychologists, pharmacists, social workers, certified case managers, and other healthcare professionals with an interest in bipolar disorder.

Financial Support:
This activity is supported by an educational grant from Janssen, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC., and from Lilly USA, LLC.

Credit Information:
This activity offers CE credit for:

  • Physicians (CME)
  • Nurses (CNE)
  • Pharmacists (ACPE)
  • Psychologists (APA)
  • Social Workers (NASW)
  • Certified Case Managers (CCMC)

All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.

CME Credit (Physicians): USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit Expiration Date: Thursday, March 8, 2012

Post-tests, credit request forms, and activity evaluations must be completed online at http://www.neuroscienceCME.com/test (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).

Faculty Disclosure:
USF Health adheres to the ACCME Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved, and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure is presented to the learner prior to registration at http://www.neuroscienceCME.com/PR545.

About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).

About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences. Clinical Compass™, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass™".

About USF Health (University of South Florida):
USF Health produces educational activities that are scientifically valid, free of commercial bias, and based on the principles of adult learning. These activities are developed around specific needs related to gaps in competence, performance, and/or patient outcomes, and, whenever possible, offer education delivered in settings best suited to the intended results.

Contact: Rachel Ellis
CME Outfitters, LLC
614.328.4506 direct
614.929.3600 fax

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rachel Ellis
Visit website